Showing results (21-30 of 64) with videos related to
Sort By:
Pageof 7
Leukemia|February 26, 2011
Immunomodulatory effects of anti-angiogenic drugsA Heine, S A E Held, A Bringmann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
T-cell receptor beta variable region diversity in melanoma metastases after interleukin 2-based immunotherapyM Willhauck, T Möhler, C Scheibenbogen, et al.Blood|December 3, 1998
Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factorP Brossart, F Grünebach, G Stuhler, et al.Cancer Research|March 4, 1998
Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytesP Brossart, G Stuhler, T Flad, et al.Cancer Research|September 15, 1995
A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral bloodP Brossart, J W Schmier, S Krüger, et al.Zeitschrift Fur Rheumatologie|April 14, 2021
[Prevalence of hypophosphatasia in adult patients in rheumatology]P Karakostas, R Dolscheid-Pommerich, M D Hass, et al.Melanoma Research|April 1, 1995
Restriction of T cell receptor V beta repertoire in melanoma metastasis responding to immunotherapyT Möhler, M Willhauck, C Scheibenbogen, et al.Cellular and Molecular Life Sciences : CMLS|March 3, 2009
Proteasome inhibition overcomes the resistance of renal cell carcinoma cells against the PPARgamma ligand troglitazoneK von Schwarzenberg, S A E Held, A Schaub, et al.Cancer Research|September 2, 2000
Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cellsP Brossart, A Zobywalski, F Grünebach, et al.Annals of the New York Academy of Sciences|July 19, 2001
Dendritic cell-based vaccines in patients with hematological malignanciesW Brugger, A Schneider, T Schammann, et al.Pageof 7